Abstract
The goal of our study was to determine the efficacy of Farabloc, an electromagnetic shielding fabric compared to placebo fabric when worn as a nightgown, as an analgesic in patients hospitalized with fibromyalgia. In a rheumatologic and rehabilitation hospital, we performed a phase 1, single-blind study of patients using Farabloc (F) or placebo (P) gowns for 8 h per night during the 20-day hospitalization and a phase 2, single-blind crossover study of patients using both F and P gowns randomly and alternatively switching after 10 of 21 days hospitalization (phase 1: 42 F, mean age 49.02 years, 35 female, 7 male; 84 P, mean age 48.08 years, 72 female, 12 males; phase 2: 25 F/P, P/F, or P/P, mean age 44.0 years, 24 female, 1 male). The study involved randomly selected and blinded use of hospital gown 8 h per night of either F or P fabric. The main outcome measures were changes from admission or midpoint to discharge in quantity of pain (QN), quality of pain (QL), and paracetamol use (PU). In phase 1, all three variables significantly favored F over P when using paired t test, two sample t test, Mann–Whitney, and analysis of covariance tests. QN was reduced (F = −2.03 ∓ 0.99*, P = 0.59 ∓ 0.71). QL was reduced (F = −10.64 ∓ 5.69*, P = −2.54 ∓ 3.40). PU was reduced (F = 10.69 ∓ 6.68*, P = 26.12 ∓ 9.37). In phase 2, comparing midpoint to discharge levels in the three variables again favored P/F over F/P and P/P (>0.001): QN (P/F +16.00 ∓ 8.35* F/P −13.27 ∓ 11.40), QL (P/F +8.71 ∓ 4.75* F/P −6.55 ∓ 5.59), and PU (F −9.29 ∓ 4.39* P −18.00 ∓ 5.27) (*p = <0.001). Patients with fibromyalgia had less pain after sleeping in a gown made of Farabloc than with a placebo fabric. This suggests that Farabloc, an electromagnetic shielding fabric, has analgesic properties in fibromyalgia. Reduced pain observation is consistent with previous studies in phantom limb pain and delayed onset muscle pain. Limitations of this study include single blind design, small sample size, and in phase 2, a lack of washout period and a F/F group.
Similar content being viewed by others
References
Eisinger J (2003) Clinical evaluation of fibromyalgia. Rev Med Intern (4):237–242 (Apr)
Henriksson KG (2003) Fibromyalgia—from syndrome to disease. Overview of pathogenic mechanisms. J Rehabil Med 41 (Suppl):89–94 (May)
Desmeules JA, Cedraschi C, Rapiti E, Baumgartner E, Finckh A, Cohen P et al (2003) Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 48(5):1420–1429 (May)
Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B et al (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 25(3):188–190
Gracely RH, Grant MA, Giesecke T (2003) Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 17(4):593–609 (Aug)
Williams DA (2003) Psychological and behavioral therapies in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 17(4):649–665 (Aug)
Clauw DJ, Crofford LJ (2003) Chronic widespread pain and fibromyalgia; what we know and what we need to know. Best Pract Res Clin Rheumatol 17(4):685–701 (Aug)
Buskila D (1999) Drug therapy. Baillieres Best Pract Res Clin Rheumatol 13(3):479–485 (Sep)
Arnold LM, Keck PE Welge JA (2000) Antidepressant treatment of fibromyalgia. Psychosomatics 41(2):104–113 (Mar–Apr)
Karjalainen K, Malmivaara A, van Tulder M, Roine R, Jauhiainen M, Hurri I et al (2000) Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working adults. Cochrane Database Sys Rev 2:CD001984
Gran JT (2003) The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17(4):547–561 (Aug)
Zhang J, Clement D, Taunton J (2000) The efficacy of Farabloc, an electromagnetic shield, in attenuating delayed onset muscle soreness. Clin J Sport Med 10(1):15–21
Conine TA, Hershler C, Alexander SA, Crisp R (1993) The efficacy of Farabloc in the treatment of phantom limb pain. Can J Rehabil 6:155–161
Gran JT (2003) The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17(4):547–561 (Aug)
Pilla AA (2002) Low-intensity electromagnetic and mechanical modulation of bone growth and repair: are they equivalent? J Orthop Sci 7(3):420–428
Neumann E, Kakorian S, Toensing K (1999) Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenerg 48(1):3–16 (Feb)
Gehl J (2003) Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 177(4):437–447 (Apr)
Bordiushkov IN, Goroshinskaia IA, Frantsiiants EM, Tkacheva GN, Gorlo EI, Neskubina IV (2000) Structural–functional changes in lymphocytes and erythrocyte membranes after exposure to alternating magnetic field. Vopr Med Khim 46(1):72–80 (Jan–Feb)
Heida T, Wagenaar JB, Rutten WL, Marani E (2002) Investigating membrane breakdown of neuronal cells exposed to nonuniform electric fields by finite-element modeling and experiments. IEEE Trans Biomed Eng 49(10):1195–1203 (Oct)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bach, G.L., Clement, D.B. Efficacy of Farabloc as an analgesic in primary fibromyalgia. Clin Rheumatol 26, 405–410 (2007). https://doi.org/10.1007/s10067-006-0494-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0494-9